Defendant “Gan Li” Countercharges “Eli Lilly” for Patent Infringement in Insulin Patent Case
August 2, 2006While the patent case of Pfizer’s “VIAGRA” has not been calmed down, the World Pharmacy Giant “Eli Lilly Company” has been involved in another patent dispute. On July 17, according to the first Finance and Commerce Daily, Beijing Ganli Pharmaceutical Co. Ltd.(hereafter referred as Ganli) has brought “Eli Lilly Company” to court for patent infringement in “Humalog” reconstructing insulin lispro. Beijing No. 1 Intermediate People’s Court will hold a court on 25 July 2006. One year ago, however, it was Eli Lilly Company who acted as the plaintiff against Ganli.
Keywords
Headquarters
Add(Beijing):7th Floor,Scitech Place,22 Jianguomenwai Avenue,Beijing 100004,China
Tel: ＋86 10 5920 8888
Fax: ＋86 10 5920 8588
E-mail: mail@unitalen.com
Newsletter
Do not miss out on the latest announcements we've provided
Networking
Unitalen Mail Box ?2016 Unitalen Attorneys at Law 版權(quán)所有 集佳知識(shí)產(chǎn)權(quán)代理有限公司 京ICP備11033076號(hào) 京公網(wǎng)安備11010502020670